Earnings Feed
Start Free
|4Feb 13, 5:50 PM ET

Bengtsson Carl Martin 4

Research Summary

AI-generated summary

Updated

Balchem (BCPC) CFO Bengtsson Receives Awards; Shares Withheld

What Happened
CFO Carl Martin Bengtsson received multiple equity awards from Balchem (BCPC) that vested on February 11–12, 2026 and had shares withheld to cover tax obligations. The filing shows awards of 3,610 shares and 4,718 performance stock units (PSUs) on 2/11/2026, plus a derivative award of 13,200 shares (acquired at $0). To satisfy tax withholding, 2,416 vested PSU shares were withheld on 2/11/2026 (value reported $431,691) and 302 restricted shares were withheld on 2/12/2026 (value $53,602). Total withholding value ≈ $485,293. These were award/vesting transactions (not open-market sales or purchases).

Key Details

  • Transaction dates: awards/vests on 2026-02-11 and 2026-02-12; Form 4 filed 2026-02-13 (filed within typical 2-business-day window).
  • Award amounts shown: 3,610 shares (restricted), 4,718 PSUs (includes 78 dividend equivalent shares), and 13,200 derivative shares (acquired at $0).
  • Withheld to cover taxes: 2,416 PSU shares withheld on 2/11/2026 (reported value $431,691); 302 restricted shares withheld on 2/12/2026 (reported value $53,602). Total withheld ≈ $485,293.
  • Footnotes of note: F2 indicates the 4,718 units were PSUs for the 2023–2025 performance period; F3/F4 confirm the 2,416 and 302 share withholdings were for tax requirements; F1 and F5 describe restricted-share and option vesting schedules.
  • Shares owned after the transactions are not specified in the provided excerpt of the filing.

Context

  • These transactions are award vestings and tax-withholdings (transaction code A for award/acquisition, F for payment of tax liability). Withholding to cover taxes is routine and is not the same as an open-market sale by the insider.
  • The 13,200 "derivative" shares reflect equity subject to vesting/option schedules (see footnote F5 for typical option vesting). The 4,718 PSUs vesting included dividend-equivalent shares per the footnotes.
  • No evidence here of a 10b5-1 sale plan or other open-market trading; this filing documents equity compensation vesting and related tax withholding only.